000			01707nam a2200253 4500
001			ESSALUD
005			20260902130441.0
007			ta
008			t pe ||||| |||| 00| 0 spa d
040			_aBMG
041			_aeng
100			_aTobias, Deirdre K. _eAutor _954368
245			_aGetting Serious about Tickborne Diseases — Shifting Research Priorities
300			_apáginas: 1971-1973
520			_aThe incidence of Lyme disease has steadily increased since the discovery of the causative agent, Borrelia burgdorferi, in 1982. In recent years, an estimated 500,000 cases have been diagnosed each year in the United States, resulting in nearly $1 billion in annual health care costs. Cases of other tickborne diseases, including anaplasmosis, babesiosis, and Powassan virus infection, have also increased (see graphs). Despite 40 years of research aimed at controlling Lyme disease, there are currently no available prevention methods that significantly reduce disease incidence in humans. Failure to address this epidemic is in part a result of the misdirection of research efforts, which have emphasized clinical disease and pathogen microbiology rather than the root cause of Lyme disease: the infected tick vectors in the environment, which remain uncontrolled.
650			_aINFECCIONES BACTERIANAS _97357
650			_aMEDICAMENTOS, DISPOSITIVOS Y LA FDA _954223
650			_aINFECCIONES PARASITARIAS _954373
650			_aVACUNAS _98158
650			_aINFECCIONES VIRALES _953766
650			_aSALUD PÚBLICA GENERAL _954132
773	0		_022717 _922665 _dMassachusetts NEJM Group _oNEJM013 _tThe New England Journal of Medicine _wESSALUD _x0028-4793
942			_cARTICULOS _e2026-08-28 _zsqb
999			_c22881 _d22881